|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06660 AIM VACCINE
Nominal 
6.990 -0.060 (-0.851%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (165,499) | (110,317) | 93,398 | 250,331 |
| Net Cash from / (used in) Investing Activities | -- | (271,958) | (858,150) | (1,337,505) | (604,917) |
| Net Cash from / (used in) Financing Activities | -- | 362,068 | 980,371 | 788,019 | 1,138,777 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (75,389) | 11,904 | (456,088) | 784,191 |
| Cash & Cash Equivalents at beginning of period | -- | 656,267 | 646,742 | 1,102,830 | 318,639 |
| Effect of Foreign Exchange Rate Changes | -- | 2,265 | (2,379) | 0 | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 583,143 | 656,267 | 646,742 | 1,102,830 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -139,254,000 |
| %Change | -44.380% |
| EPS / (LPS) | RMB -0.110 |
| NBV Per Share (¥) | RMB 2.893 |